## Pathophysiology of Post-Infarction Heart Failure ### Acute Phase (Ischemic Injury) During acute myocardial infarction, the occluded coronary artery causes: 1. Cessation of aerobic metabolism 2. Rapid ATP depletion 3. Failure of Na-K-ATPase → intracellular Na^+^ and Ca^2+^ accumulation 4. Myocardial necrosis in the distribution of the occluded vessel ### Chronic Phase (Remodeling & Heart Failure) After successful reperfusion, surviving myocardium undergoes maladaptive remodeling: **Key Point:** The transition to chronic heart failure is driven by **neurohormonal activation**, not by persistent ischemia. The infarcted zone and surviving myocardium trigger compensatory mechanisms that ultimately become pathological. ### Cellular Mechanisms of Remodeling | Mechanism | Effect | Consequence | |-----------|--------|-------------| | **Sympathetic activation** | ↑ β-adrenergic signaling | ↑ intracellular Ca^2+^, ↑ contractility initially, then arrhythmias | | **RAAS activation** | ↑ Angiotensin II, aldosterone | Vasoconstriction, Na^+^ retention, fluid overload | | **Increased afterload** | Compensatory hypertrophy | Eccentric remodeling, chamber dilation | | **Chronic Ca^2+^ overload** | Calcineurin activation | Myocardial fibrosis, apoptosis | | **Inflammatory cytokines** | TNF-α, IL-6 | Cardiomyocyte apoptosis, collagen deposition | **High-Yield:** The progression from acute MI to dilated cardiomyopathy and heart failure is mediated by **sustained activation of the sympathetic nervous system and RAAS**, not by the acute ischemic injury itself. This is why ACE inhibitors, β-blockers, and aldosterone antagonists improve outcomes. ### Why This Patient Developed Heart Failure **Clinical Pearl:** Despite successful reperfusion (angiography shows patent stent), the patient developed systolic dysfunction because: - The infarct size was large (inferior wall MI with global hypokinesis suggests extensive myocardial loss) - Surviving myocardium underwent pathological remodeling driven by neurohormonal activation - Increased intracellular Ca^2+^ in viable myocytes → activation of calcineurin → fibrosis and apoptosis **Mnemonic: RAAS-SNS Loop in HF** — **R**enin-**A**ngiotensin-**A**ldosterone **S**ystem and **S**ympathetic **N**ervous **S**ystem create a vicious cycle: ↓ CO → ↑ RAAS/SNS → ↑ afterload → ↑ Ca^2+^ → fibrosis → ↓ EF → ↓ CO (repeat). ## Why Other Options Are Wrong **Option 1 (Correct):** Explains the chronic remodeling phase post-MI, which is the clinical presentation here (dilated LV, reduced EF, symptoms 48 hours later). **Option 2:** While ATP depletion does occur during acute ischemia, it is reversible upon reperfusion (which occurred here after successful PCI). The Na-K-ATPase recovers function once oxygen is restored. This does not explain the *progressive* dysfunction 48 hours after reperfusion. **Option 3:** Calcium-mediated proteolysis (calpain activation) does occur during ischemia-reperfusion injury, but it is acute and self-limited, not the driver of chronic remodeling. Actin-myosin cross-linking is not permanent; sarcomeres are continuously remodeled. **Option 4:** Cardiomyocytes do not transdifferentiate into smooth muscle cells in response to chronic ischemia. This is biologically implausible and not supported by evidence. Fibroblasts may proliferate (fibrosis), but cardiomyocytes do not change cell type.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.